- Home
- / Tyra Biosciences
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Tyra Biosciences financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$16.9
2024-10-29
Market Capitalization
$893 M
2024-10-29
CreditSafe Score
?
Score changed on Jun 17, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|
| General and administrative expense | 5.7M | 15.9M | 17.4M | 24.1M | 29.8M |
| Operating expense total | 26.3M | 58.9M | 104.2M | 132.8M | |
| EBIT | (26.3M) | (58.9M) | (79.9M) | (104.2M) | (132.8M) |
| Interest income | 17.7M | 12.8M | |||
| Income tax expense | 1.0K | 2.0K | |||
| Net Income | (26.3M) | (55.3M) | (69.1M) | (86.5M) | (119.9M) |
| EPS | (1.3) | (1.0) | (1.5) | (2.0) |